Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    August 2022
  1. COHEN J
    Making broader coronavirus vaccines is a struggle.
    Science. 2022;377:566-567.
    >> Share

    July 2022
    The ascent of ModernaThe Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World Peter Loftus Harvard Business Review Press, 2022. 320 pp.
    Science. 2022;377:479.
    >> Share

  3. BOWEN JE, Addetia A, Dang HV, Stewart C, et al
    Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
    Science. 2022 Jul 19:eabq0203. doi: 10.1126/science.abq0203.
    >> Share

  4. CHEN R, Guo X, Zhu A
    Vaccinate to combat COVID-19 in China.
    Science. 2022;377:271.
    >> Share

    June 2022
  5. REYNOLDS CJ, Pade C, Gibbons JM, Otter AD, et al
    Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.
    Science. 2022 Jun 14:eabq1841. doi: 10.1126/science.abq1841.
    >> Share

    Monkeypox vaccination plans take shape amid questions.
    Science. 2022;376:1142-1143.
    >> Share

    May 2022
    Wrestling with bird flu, Europe considers once-taboo vaccines.
    Science. 2022;376:682-683.
    >> Share

    Better lipids to power next generation of mRNA vaccines.
    Science. 2022;376:680-681.
    >> Share

  9. VOGEL G
    New subvariants are masters of immune evasion.
    Science. 2022;376:679-680.
    >> Share

    April 2022
  10. COHEN J
    First self-copying mRNA vaccine proves itself in pandemic trial.
    Science. 2022;376:446.
    >> Share

  11. PULLA P
    India's speedy vaccine approvals come under fire.
    Science. 2022;376:442-443.
    >> Share

  12. ARINAMINPATHY N, Saad-Roy CM, Yang Q, Ahmad I, et al
    A global system for the next generation of vaccines.
    Science. 2022;376:462-464.
    >> Share

    Global project gears up to study vaccine safety.
    Science. 2022;376:227-228.
    >> Share

  14. COHEN J
    New crop of mRNA vaccines aim for accessibility.
    Science. 2022;376:120-121.
    >> Share

    Japan reboots HPV vaccination drive after 9-year gap.
    Science. 2022;376:14.
    >> Share

    March 2022
  16. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Self-spreading vaccines: Base policy on evidence-Response.
    Science. 2022;375:1363.
    >> Share

  17. STREICKER DG, Bull JJ, Nuismer SL
    Self-spreading vaccines: Base policy on evidence.
    Science. 2022;375:1362-1363.
    >> Share

  18. DEAN NE, Halloran ME
    Protecting the herd with vaccination.
    Science. 2022;375:1088-1089.
    >> Share

  19. ALTMANN DM, Boyton RJ
    COVID-19 vaccination: The road ahead.
    Science. 2022;375:1127-1132.
    >> Share

  20. EDWARDS AM, Baric RS, Saphire EO, Ulmer JB, et al
    Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Science. 2022;375:1133-1139.
    >> Share

  21. KOELLE K, Martin MA, Antia R, Lopman B, et al
    The changing epidemiology of SARS-CoV-2.
    Science. 2022;375:1116-1121.
    >> Share

  22. MOBARAK AM, Miguel E, Abaluck J, Ahuja A, et al
    End COVID-19 in low- and middle-income countries.
    Science. 2022;375:1105-1110.
    >> Share

    Africa battles out-of-control polio outbreaks.
    Science. 2022;375:1079-1080.
    >> Share

    February 2022
    One antibody to treat them all.
    Science. 2022;375:803.
    >> Share

  25. ROURKE M, Eccleston-Turner M, Switzer S
    Sovereignty, sanctions, and data sharing under international law.
    Science. 2022;375:724-726.
    >> Share

  26. KAKU CI, Champney ER, Normark J, Garcia M, et al
    Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
    Science. 2022 Feb 10:eabn2688. doi: 10.1126/science.abn2688.
    >> Share

  27. ELLIOTT P, Bodinier B, Eales O, Wang H, et al
    Rapid increase in Omicron infections in England during December 2021: REACT-1 study.
    Science. 2022 Feb 8:eabn8347. doi: 10.1126/science.abn8347.
    >> Share

  28. WADMAN M
    New Omicron begins to take over, despite late start.
    Science. 2022;375:480-481.
    >> Share

    January 2022
    Vaccines may cause rare, Long Covid-like symptoms.
    Science. 2022;375:364-366.
    >> Share

    After Omicron, some scientists foresee 'a period of quiet'.
    Science. 2022;375:366-367.
    >> Share

  31. HAYEK S, Shaham G, Ben-Shlomo Y, Kepten E, et al
    Indirect protection of children from SARS-CoV-2 infection through parental vaccination.
    Science. 2022 Jan 27:eabm3087. doi: 10.1126/science.abm3087.
    >> Share

  32. PRUNAS O, Warren JL, Crawford FW, Gazit S, et al
    Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.
    Science. 2022 Jan 27:eabl4292. doi: 10.1126/science.abl4292.
    >> Share

  33. WADMAN M
    Studies reveal dangers of SARS-CoV-2 infection in pregnancy.
    Science. 2022;375:253.
    >> Share

  34. MANNAR D, Saville JW, Zhu X, Srivastava SS, et al
    SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.
    Science. 2022 Jan 20:eabn7760. doi: 10.1126/science.abn7760.
    >> Share

  35. MUIK A, Lui BG, Wallisch AK, Bacher M, et al
    Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
    Science. 2022 Jan 18:eabn7591. doi: 10.1126/science.abn7591.
    >> Share

  36. KAISER J
    Study of soldiers implicates common virus as MS trigger.
    Science. 2022;375:133.
    >> Share

    Using correlates to accelerate vaccinology.
    Science. 2022;375:22-23.
    >> Share

  38. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Eroding norms over release of self-spreading viruses.
    Science. 2022;375:31-33.
    >> Share

    Omicron threat remains fuzzy as cases explode.
    Science. 2022;375:9-10.
    >> Share

    December 2021
  40. GUPTA RK, Topol EJ
    COVID-19 vaccine breakthrough infections.
    Science. 2021;374:1561-1562.
    >> Share

  41. COHEN J
    Will global vaccine shortfalls end in 2022?
    Science. 2021;374:1546.
    >> Share

  42. COHEN J
    Omicron sparks a vaccine strategy debate.
    Science. 2021;374:1544-1545.
    >> Share

  43. VOGEL G, Kupferschmidt K
    Early lab studies shed light on Omicron's behavior.
    Science. 2021;374:1543-1544.
    >> Share

  44. CERNUSCHI T, Malvolti S, Downham M, Maugeais D, et al
    COVID-19 impact on infant and adolescent vaccine supplies.
    Science. 2021;374:1438-1441.
    >> Share

    Missed shots.
    Science. 2021;374:1434-1435.
    >> Share

    Scientists see a 'really, really tough winter' with Omicron.
    Science. 2021;374:1421-1422.
    >> Share

    How bad is Omicron? Some clues are emerging.
    Science. 2021;374:1304-1305.
    >> Share

    Where did 'weird' Omicron come from?
    Science. 2021;374:1179.
    >> Share

  49. REYNOLDS CJ, Gibbons JM, Pade C, Lin KM, et al
    Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
    Science. 2021 Dec 2:eabm0811.
    >> Share

  50. NABEL KG, Clark SA, Shankar S, Pan J, et al
    Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
    Science. 2021 Dec 2:eabl6251.
    >> Share

    November 2021
  51. GILBERT PB, Montefiori DC, McDermott AB, Fong Y, et al
    Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
    Science. 2021 Nov 23:eab3435.
    >> Share

  52. WADMAN M
    To fight Lyme disease, vaccine targets ticks.
    Science. 2021;374:925.
    >> Share

  53. GERBER JS, Offit PA
    COVID-19 vaccines for children.
    Science. 2021;374:913.
    >> Share

    'Zero COVID' is getting harder-but China is sticking with it.
    Science. 2021;374:924.
    >> Share

    Cash incentives, ethics, and COVID-19 vaccination.
    Science. 2021;374:819-820.
    >> Share

  56. MCCALLUM M, Walls AC, Sprouse KR, Bowen JE, et al
    Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.
    Science. 2021 Nov 9:eabl8506. doi: 10.1126/science.abl8506.
    >> Share

    Children and COVID-19 in schools.
    Science. 2021;374:680-682.
    >> Share

  58. COHN BA, Cirillo PM, Murphy CC, Krigbaum NY, et al
    SARS-CoV-2 vaccine protection and deaths among US veterans during 2021.
    Science. 2021 Nov 4:eabm0620. doi: 10.1126/science.abm0620.
    >> Share

  59. ELLIOTT P, Haw D, Wang H, Eales O, et al
    Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
    Science. 2021 Nov 2:eabl9551. doi: 10.1126/science.abl9551.
    >> Share

    October 2021
  60. KRISHTEL P, Hassan F
    Share vaccine know-how.
    Science. 2021;374:379.
    >> Share

    Polio vaccination to resume across Afghanistan.
    Science. 2021;374:382.
    >> Share

  62. CORBETT KS, Gagne M, Wagner DA, O' Connell S, et al
    Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates.
    Science. 2021 Oct 21:eabl8912. doi: 10.1126/science.abl8912.
    >> Share

  63. VOGEL G
    WHO gives first malaria vaccine the green light.
    Science. 2021;374:245-246.
    >> Share

  64. GOEL RR, Painter MM, Apostolidis SA, Mathew D, et al
    mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
    Science. 2021 Oct 14:eabm0829. doi: 10.1126/science.abm0829.
    >> Share

  65. CAMPOS-MERCADE P, Meier AN, Schneider FH, Meier S, et al
    Monetary incentives increase COVID-19 vaccinations.
    Science. 2021 Oct 7:eabm0475. doi: 10.1126/science.abm0475.
    >> Share

  66. COHEN J
    New Chinese vaccine could bolster global arsenal.
    Science. 2021;374:12-13.
    >> Share

    September 2021
  67. WADMAN M
    Israel's high case plateau may offer worrisome portent.
    Science. 2021;373:1428-1429.
    >> Share

  68. CORBETT KS, Nason MC, Flach B, Gagne M, et al
    Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.
    Science. 2021;373:eabj0299.
    >> Share

  69. COHEN J
    Vaccine equity hopes dashed.
    Science. 2021;373:1297.
    >> Share

  70. MATEUS J, Dan JM, Zhang Z, Rydyznski Moderbacher C, et al
    Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells.
    Science. 2021 Sep 14:eabj9853. doi: 10.1126/science.abj9853.
    >> Share

  71. WADMAN M
    SARS-CoV-2 infection confers greater immunity than shots.
    Science. 2021;373:1067-1068.
    >> Share

    August 2021
  72. LOYAL L, Braun J, Henze L, Kruse B, et al
    Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
    Science. 2021 Aug 31. pii: science.abh1823. doi: 10.1126/science.abh1823.
    >> Share

    Colleges must require vaccination.
    Science. 2021;373:945.
    >> Share

  74. COHEN J
    Antibody acts like short-term malaria vaccine.
    Science. 2021;373:843.
    >> Share

    Evolving threat.
    Science. 2021;373:844-849.
    >> Share

  76. WADMAN M
    Israel's grim warning: Delta can overwhelm shots.
    Science. 2021;373:838-839.
    >> Share

  77. WAGNER CE, Saad-Roy CM, Morris SE, Baker RE, et al
    Vaccine nationalism and the dynamics and control of SARS-CoV-2.
    Science. 2021 Aug 17. pii: science.abj7364. doi: 10.1126/science.abj7364.
    >> Share

  78. FAUSTHER-BOVENDO H, Kobinger G
    Plant-made vaccines and therapeutics.
    Science. 2021;373:740-741.
    >> Share

  79. PEGU A, O'Connell S, Schmidt SD, O'Dell S, et al
    Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
    Science. 2021 Aug 12. pii: science.abj4176. doi: 10.1126/science.abj4176.
    >> Share

  80. OZA A
    Studies probe how payouts affect U.S. vaccination rates.
    Science. 2021;373:611.
    >> Share

  81. PINTO D, Sauer MM, Czudnochowski N, Low JS, et al
    Broad betacoronavirus neutralization by a stem helix-specific human antibody.
    Science. 2021 Aug 3. pii: science.abj3321. doi: 10.1126/science.abj3321.
    >> Share

    July 2021
  82. WADMAN M
    The overlooked superpower of mRNA vaccines.
    Science. 2021;373:479.
    >> Share

  83. LUND FE, Randall TD
    Scent of a vaccine.
    Science. 2021;373:397-399.
    >> Share

  84. THORP HH
    Colleges need vaccine mandates.
    Science. 2021;373:369.
    >> Share

  85. WADMAN M
    Journal retracts paper claiming COVID-19 vaccines kill.
    Science. 2021;373:147.
    >> Share

  86. COHEN J
    Can immune responses predict which vaccines work best?
    Science. 2021;373:142-143.
    >> Share

  87. O'GRADY C
    Sex and gender missing in COVID-19 data.
    Science. 2021;373:145.
    >> Share

  88. MCCALLUM M, Bassi J, De Marco A, Chen A, et al
    SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
    Science. 2021 Jul 1. pii: science.abi7994. doi: 10.1126/science.abi7994.
    >> Share

    June 2021
  89. MARTINEZ DR, Schafer A, Leist SR, De la Cruz G, et al
    Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.
    Science. 2021 Jun 22. pii: science.abi4506. doi: 10.1126/science.abi4506.
    >> Share

  90. VOGEL G
    Mixing vaccines may boost immune responses.
    Science. 2021;372:1138.
    >> Share

  91. COHEN J
    'Landmark' African vaccine trial faces impasse.
    Science. 2021;372:1135-1136.
    >> Share

    May 2021
  92. BALICER RD, Ohana R
    Israel's COVID-19 endgame.
    Science. 2021;372:663.
    >> Share

    Preventing respiratory syncytial virus (RSV) disease in children.
    Science. 2021;372:686-687.
    >> Share

  94. MOUTINHO S, Wadman M
    Brazil and Russia face off over vaccine contamination charge.
    Science. 2021;372:554.
    >> Share

    April 2021
  95. REYNOLDS CJ, Pade C, Gibbons JM, Butler DK, et al
    Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.
    Science. 2021 Apr 30. pii: science.abh1282. doi: 10.1126/science.abh1282.
    >> Share

  96. WADMAN M
    Malaria vaccine achieves striking early success.
    Science. 2021;372:448.
    >> Share

    Relief and worry for immune-suppressed people.
    Science. 2021;372:443-444.
    >> Share

    After vaccine failures, France laments biomedical decline.
    Science. 2021;372:331-332.
    >> Share

  99. HANAGE WP, Russell CA
    Partial immunity and SARS-CoV-2 mutations.
    Science. 2021;372:354.
    >> Share

  100. COHEN J
    The dream vaccine.
    Science. 2021;372:227-231.
    >> Share

    Vaccine link to serious clotting disorder firms up.
    Science. 2021;372:220-221.
    >> Share

    Latest Russian vaccine comes with a big dose of mystery.
    Science. 2021;372:116-117.
    >> Share

  103. FAUCI AS
    The story behind COVID-19 vaccines.
    Science. 2021;372:109.
    >> Share

  104. VOGEL G, Kupferschmidt K
    Side effect worry grows for AstraZeneca vaccine.
    Science. 2021;372:14-15.
    >> Share

    India speeds up vaccinations as cases soar again.
    Science. 2021;372:12-13.
    >> Share

    March 2021
  106. VOGEL G, Kupferschmidt K
    New problems erode confidence in AstraZeneca's vaccine.
    Science. 2021;371:1294-1295.
    >> Share

  107. LARSON HJ, Broniatowski DA
    Volatility of vaccine confidence.
    Science. 2021;371:1289.
    >> Share

  108. MCCORMICK KD, Jacobs JL, Mellors JW
    The emerging plasticity of SARS-CoV-2.
    Science. 2021;371:1306-1308.
    >> Share

    Deadly viral outbreak ravages European horses.
    Science. 2021;371:1297.
    >> Share

  110. STAMATATOS L, Czartoski J, Wan YH, Homad LJ, et al
    mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
    Science. 2021 Mar 25. pii: science.abg9175. doi: 10.1126/science.abg9175.
    >> Share

  111. VERWEIJ M, Hansen SG, Iyer R, John N, et al
    Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.
    Science. 2021 Mar 25. pii: science.abe9233. doi: 10.1126/science.abe9233.
    >> Share

  112. DYE C, Mills MC
    COVID-19 vaccination passports.
    Science. 2021;371:1184.
    >> Share

  113. LUCHSINGER LL, Hillyer CD
    Vaccine efficacy probable against COVID-19 variants.
    Science. 2021;371:1116.
    >> Share

  114. COHEN J, Kupferschmidt K
    As vaccine surpluses loom, donation plans urged.
    Science. 2021;371:1087-1088.
    >> Share

  115. ALTMANN DM, Boyton RJ, Beale R
    Immunity to SARS-CoV-2 variants of concern.
    Science. 2021;371:1103-1104.
    >> Share

  116. SAAD-ROY CM, Morris SE, Metcalf CJE, Mina MJ, et al
    Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.
    Science. 2021 Mar 9. pii: science.abg8663. doi: 10.1126/science.abg8663.
    >> Share

  117. DAVIES NG, Abbott S, Barnard RC, Jarvis CI, et al
    Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
    Science. 2021 Mar 3. pii: science.abg3055. doi: 10.1126/science.abg3055.
    >> Share

    February 2021
    Vaccine trials ramp up in children and adolescents.
    Science. 2021;371:874-875.
    >> Share

  119. CASTILLO JC, Ahuja A, Athey S, Baker A, et al
    Market design to accelerate COVID-19 vaccine supply.
    Science. 2021 Feb 25. pii: science.abg0889. doi: 10.1126/science.abg0889.
    >> Share

    Deaths of health workers in Africa highlight vaccine inequity.
    Science. 2021;371:764-765.
    >> Share

    France turns to citizens' panel to reduce vaccine skepticism.
    Science. 2021;371:763-764.
    >> Share

  122. KOFF WC, Berkley SF
    A universal coronavirus vaccine.
    Science. 2021;371:759.
    >> Share

  123. COHEN J
    The long road.
    Science. 2021;371:768-772.
    >> Share

  124. COHEN J
    Two new vaccines deliver good and bad news for the pandemic.
    Science. 2021;371:548-549.
    >> Share

  125. MONOD M, Blenkinsop A, Xi X, Hebert D, et al
    Age groups that sustain resurging COVID-19 epidemics in the United States.
    Science. 2021 Feb 2. pii: science.abe8372. doi: 10.1126/science.abe8372.
    >> Share

    January 2021
  126. MUIK A, Wallisch AK, Sanger B, Swanson KA, et al
    Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.
    Science. 2021 Jan 29. pii: science.abg6105. doi: 10.1126/science.abg6105.
    >> Share

  127. PROVINE NM, Amini A, Garner LC, Spencer AJ, et al
    MAIT cell activation augments adenovirus vector vaccine immunogenicity.
    Science. 2021;371:521-526.
    >> Share

  128. GALANTI M, Pei S, Yamana TK, Angulo FJ, et al
    Social distancing remains key during vaccinations.
    Science. 2021;371:473-474.
    >> Share

  129. JUNO JA, O'Connor SL
    Translating viral vaccines into immunity.
    Science. 2021;371:460-461.
    >> Share

  130. COHEN J
    Ex-vaccine chief reflects on triumphs, failures, and Trump.
    Science. 2021;371:449-450.
    >> Share

    Vaccinemakers ponder how to adapt to virus variants.
    Science. 2021;371:448-449.
    >> Share

  132. FITZPATRICK MC, Galvani AP
    Optimizing age-specific vaccination.
    Science. 2021 Jan 21. pii: science.abg2334. doi: 10.1126/science.abg2334.
    >> Share

  133. BUBAR KM, Reinholt K, Kissler SM, Lipsitch M, et al
    Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.
    Science. 2021 Jan 21. pii: science.abe6959. doi: 10.1126/science.abe6959.
    >> Share

  134. Q&A: How to market vaccination.
    Science. 2021;371:223.
    >> Share

  135. NORMILE D
    Pandemic could mark 'turning point' for Chinese science.
    Science. 2021;371:222-223.
    >> Share

  136. THORP HH
    Public debate is good for science.
    Science. 2021;371:213.
    >> Share

  137. LAVINE JS, Bjornstad ON, Antia R
    Immunological characteristics govern the transition of COVID-19 to endemicity.
    Science. 2021 Jan 12. pii: science.abe6522. doi: 10.1126/science.abe6522.
    >> Share

  138. COHEN AA, Gnanapragasam PNP, Lee YE, Hoffman PR, et al
    Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.
    Science. 2021 Jan 12. pii: science.abf6840. doi: 10.1126/science.abf6840.
    >> Share

  139. KRIENKE C, Kolb L, Diken E, Streuber M, et al
    A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.
    Science. 2021;371:145-153.
    >> Share

  140. COHEN J
    Dosing debates, transparency issues roil vaccine rollouts.
    Science. 2021;371:109-110.
    >> Share

  141. DE VRIEZE J
    Pfizer's vaccine raises allergy concerns.
    Science. 2021;371:10-11.
    >> Share

    December 2020
  142. LARSEN MD, de Graaf EL, Sonneveld ME, Plomp HR, et al
    Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
    Science. 2020 Dec 23. pii: science.abc8378. doi: 10.1126/science.abc8378.
    >> Share

  143. CAPLAN A, Bateman-House A
    Transparency is key to ethical vaccine research-Response.
    Science. 2020;370:1423-1424.
    >> Share

  144. GUERRINI CJ, Sherkow JS, Meyer MN, Zettler PJ, et al
    Transparency is key to ethical vaccine research-Response.
    Science. 2020;370:1423.
    >> Share

  145. ESTEP PW, Church GM
    Transparency is key to ethical vaccine research.
    Science. 2020;370:1422-1423.
    >> Share

  146. COHEN J, Kupferschmidt K
    As vaccines emerge, a global waiting game begins.
    Science. 2020;370:1385-1387.
    >> Share

  147. COHEN J
    Shots of hope.
    Science. 2020;370:1392-1394.
    >> Share

  148. SERVICK K
    mRNA's next challenge: Will it work as a drug?
    Science. 2020;370:1388-1389.
    >> Share

  149. COHEN J
    China's vaccine gambit.
    Science. 2020;370:1263-1267.
    >> Share

  150. THORP HH
    An opportunity to improve innovation.
    Science. 2020;370:1251.
    >> Share

  151. COHEN J
    Amid the cheering, some vaccines face questions.
    Science. 2020;370:1151.
    >> Share

    New challenges emerge for planned human challenge trials.
    Science. 2020;370:1150.
    >> Share

  153. WENDLER D, Ochoa J, Millum J, Grady C, et al
    COVID-19 vaccine trial ethics once we have efficacious vaccines.
    Science. 2020 Dec 3. pii: science.abf5084. doi: 10.1126/science.abf5084.
    >> Share

    November 2020
  154. WADMAN M
    Public needs to prep for vaccine side effects.
    Science. 2020;370:1022.
    >> Share

  155. COHEN J
    Vaccine wagers on coronavirus surface protein pay off.
    Science. 2020;370:894-895.
    >> Share

  156. GUPTA R
    Advancing new tools for infectious diseases.
    Science. 2020;370:913-914.
    >> Share

  157. KNIPE DM, Levy O, Fitzgerald KA, Muhlberger E, et al
    Ensuring vaccine safety.
    Science. 2020 Nov 17. pii: science.abf0357. doi: 10.1126/science.abf0357.
    >> Share

  158. ROBERTS L
    New polio vaccine could boost faltering eradication drive.
    Science. 2020;370:751-752.
    >> Share

  159. COHEN J
    Effective vaccine offers shot of hope for pandemic.
    Science. 2020;370:748-749.
    >> Share

  160. WADMAN M
    'Nothing is impossible,' says lab ace Nita Patel.
    Science. 2020;370:652.
    >> Share

  161. WADMAN M
    The long shot.
    Science. 2020;370:649-653.
    >> Share

    October 2020
  162. COHEN J
    First vaccine may stymie hunt for better ones.
    Science. 2020;370:389-390.
    >> Share

  163. LIPSITCH M, Dean NE
    Understanding COVID-19 vaccine efficacy.
    Science. 2020 Oct 21. pii: science.abe5938. doi: 10.1126/science.abe5938.
    >> Share

  164. BANGARU S, Ozorowski G, Turner HL, Antanasijevic A, et al
    Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
    Science. 2020 Oct 20. pii: science.abe1502. doi: 10.1126/science.abe1502.
    >> Share

  165. THORP HH
    Not throwing away our shot.
    Science. 2020;370:266.
    >> Share

  166. COHEN J
    A call to test new vaccines head to head, in monkeys.
    Science. 2020;370:154-155.
    >> Share

    September 2020
  167. GUERRINI CJ, Sherkow JS, Meyer MN, Zettler PJ, et al
    Self-experimentation, ethics, and regulation of vaccines.
    Science. 2020;369:1570-1572.
    >> Share

    Despite obstacles, WHO unveils plan to distribute vaccine.
    Science. 2020;369:1553.
    >> Share

  169. SAAD-ROY CM, Wagner CE, Baker RE, Morris SE, et al
    Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.
    Science. 2020 Sep 21. pii: science.abd7343. doi: 10.1126/science.abd7343.
    >> Share

    August 2020
  170. KATZELNICK LC, Narvaez C, Arguello S, Lopez Mercado B, et al
    Zika virus infection enhances future risk of severe dengue disease.
    Science. 2020;369:1123-1128.
    >> Share

    July 2020
  171. HSIEH CL, Goldsmith JA, Schaub JM, DiVenere AM, et al
    Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
    Science. 2020 Jul 23. pii: science.abd0826. doi: 10.1126/science.abd0826.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016